Meseclazone (W-2395), also known as 2-methylseclazone, is a nonsteroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]

Meseclazone
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 7-chloro-2-methyl-3,3a-dihydro-2H,9H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H10ClNO3
Molar mass239.66 g·mol−1
3D model (JSmol)
  • Clc2cc1C(=O)N3OC(CC3Oc1cc2)C

See also

edit

References

edit
  1. ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
  2. ^ a b c Rainsford KD (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.